Chitosan–interferon-β gene complex powder for inhalation treatment of lung metastasis in mice
Authors:
- Hirokazu OkamotoHOHirokazu Okamoto
- Keiko ShirakiKSKeiko Shiraki
- Reiko YasudaRYReiko Yasuda
- Kazumi DanjoKDKazumi Danjo
- Yoshihiko WatanabeYWYoshihiko Watanabe
- 1 March 2011
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 150 (2) , 187-195
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 34 references indexed in Scilit:
- Biodistribution and pharmacokinetics of aerosol and intravenously administered dna–polyethyleneimine complexes: optimization of pulmonary delivery and retentionMolecular Therapy, 2003
- Therapeutic Effect of Intravenous Interferon Gene Delivery with Naked Plasmid DNA in Murine Metastasis ModelsMolecular Therapy, 2002
- Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI– p53 complexesCancer Gene Therapy, 2001
- Successful Treatment of Primary and Disseminated Human Lung Cancers by Systemic Delivery of Tumor Suppressor Genes Using an Improved Liposome VectorMolecular Therapy, 2001
- Inhibition of Experimental Lung Metastasis by Aerosol Delivery of PEI–p53 ComplexesMolecular Therapy, 2000
- Strength of conjugate binding to plasmid DNA affects degradation rate and expression level in vivoBiochimica et Biophysica Acta (BBA) - General Subjects, 2000
- Development of cationic liposome formulations for intratracheal gene therapy of early lung cancerCancer Gene Therapy, 2000
- Intravenous Cytokine Gene Delivery by Lipid-DNA Complexes Controls the Growth of Established Lung MetastasesHuman Gene Therapy, 1999
- Biodistribution of Radiolabeled Lipid–DNA Complexes and DNA in MiceJournal of Pharmaceutical Sciences, 1998
- Drug delivery to the respiratory tract using dry powder inhalersInternational Journal of Pharmaceutics, 1994